University of California San Francisco

Jason Chan large
Jason Chan, MD

Radiation oncologist
East Coast transplant

Address

1600 Divisadero, #H1031
San Francisco, CA 94115
United States

Email: [email protected]
Phone: 415-353-7175

    Education

    Institution Degree Dept or School End Date
    Brown University MD
    University of California, San Francisco Residency

    Clinical Trials

    1. Related Conditions: Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma, Hypopharyngeal Cancer, Oropharyngeal Cancer, Head and Neck Cancer, Carcinoma| Start Date: | End Date:
    2. Related Conditions: Head and Neck Cancer, Head and Neck Squamous Cell Carcinoma, Squamous Cell Carcinoma, Head and Neck Tumor, Carcinoma| Start Date: | End Date:
    3. Related Conditions: Squamous Cell Carcinoma, Hypopharyngeal Cancer, Oropharyngeal Cancer, Head and Neck Cancer, Immunotherapy, Carcinoma, Head and Neck Squamous Cell Carcinoma| Start Date: | End Date:

    Publications

    MOST RECENT PUBLICATIONS FROM A TOTAL OF 45
    1. Higher area deprivation index is associated with poorer local control and overall survival in non-metastatic nasopharyngeal carcinoma.
      Malik NH, Montero M, Chen JJ, Sinha S, Yom SS, Chan JW| | PubMed
    2. Evaluating the Hounsfield unit assignment and dose differences between CT-based standard and deep learning-based synthetic CT images for MRI-only radiation therapy of the head and neck.
      Singhrao K, Dugan CL, Calvin C, Pelayo L, Yom SS, Chan JW, Scholey JE, Singer L| | PubMed
    3. Incidental findings and safety events from magnetic resonance imaging simulation for head and neck radiation treatment planning: A single institution experience.
      Massachi J, Singer L, Glastonbury C, Scholey J, Singhrao K, Calvin C, Yom SS, Chan JW| | PubMed
    4. Targeted gene expression profiling predicts meningioma outcomes and radiotherapy responses.
      Chen WC, Choudhury A, Youngblood MW, Polley MC, Lucas CG, Mirchia K, Maas SLN, Suwala AK, Won M, Bayley JC, Harmanci AS, Harmanci AO, Klisch TJ, Nguyen MP, Vasudevan HN, McCortney K, Yu TJ, Bhave V, Lam TC, Pu JK, Li LF, Leung GK, Chan JW, Perlow HK, Palmer JD, Haberler C, Berghoff AS, Preusser M, Nicolaides TP, Mawrin C, Agnihotri S, Resnick A, Rood BR, Chew J, Young JS, Boreta L, Braunstein SE, Schulte J, Butowski N, Santagata S, Spetzler D, Bush NAO, Villanueva-Meyer JE, Chandler JP, Solomon DA, Rogers CL, Pugh SL, Mehta MP, Sneed PK, Berger MS, Horbinski CM, McDermott MW, Perry A, Bi WL, Patel AJ, Sahm F, Magill ST, Raleigh DR| | PubMed
    5. Treatment Modality Impact on Patient-Reported Quality of Life in Human Papilloma Virus-Associated Oropharyngeal Carcinoma.
      Plonowska-Hirschfeld KA, Gulati A, Stephens EM, Ochoa E, Xu MJ, Ha PK, Heaton CM, Yom SS, Chan JW, Algazi A, Kang H, Ryan WR| | PubMed
    6. A prospective evaluation of neck and shoulder function following treatments of early-stage human papillomavirus-associated oropharynx cancer.
      Gulati A, Plonowska-Hirschfeld K, Stephens EM, Kansara S, Zebolsky AL, Ochoa E, Xu MJ, Ha PK, Heaton CM, Yom SS, Chan JW, Algazi AP, Kang H, Ryan WR| | PubMed
    7. Integrating CT-based radiomic model with clinical features improves long-term prognostication in high-risk prostate cancer.
      Ching JCF, Lam S, Lam CCH, Lui AOY, Kwong JCK, Lo AYH, Chan JWH, Cai J, Leung WS, Lee SWY| | PubMed
    8. Early-Stage Primary Lung Neuroendocrine Tumors Treated With Stereotactic Body Radiation Therapy: A Multi-Institution Experience.
      Oliver DE, Laborde JM, Singh DP, Milano MT, Videtic GM, Williams GR, LaRiviere MJ, Chan JW, Peters GW, Decker RH, Samson P, Robinson CG, Breen WG, Owen D, Tian S, Higgins KA, Almeldin D, Jabbour SK, Wang F, Grass GD, Perez BA, Dilling TJ, Strosberg J, Rosenberg SA| | PubMed
    9. Approaches to the Management of Metastatic Adenoid Cystic Carcinoma.
      Lee RH, Wai KC, Chan JW, Ha PK, Kang H| | PubMed
    10. Just Because You Could, Does Not Mean You Should.
      Sinha S, Chan JW| | PubMed
    11. The Role of Chemotherapy Plus Immune Checkpoint Inhibitors in Oncogenic-Driven NSCLC: A University of California Lung Cancer Consortium Retrospective Study.
      Benjamin DJ, Chen S, Eldredge JB, Schokrpur S, Li D, Quan Z, Chan JW, Cummings AL, Daly ME, Goldman JW, Gubens MA, Harris JP, Onaitis MW, Zhu VW, Patel SP, Kelly K| | PubMed
    12. 18F-FDG PET/CT Prediction of Treatment Outcomes in Human Papillomavirus-Positive, Locally Advanced Oropharyngeal Cancer Patients Receiving Deintensified Therapy: Results from NRG-HN002.
      Subramaniam RM, DeMora L, Yao M, Yom SS, Gillison M, Caudell JJ, Waldron J, Xia P, Chung CH, Truong MT, Echevarria M, Chan JW, Geiger JL, Mell L, Seaward S, Thorstad WL, Beitler JJ, Sultanem K, Blakaj D, Le QT| | PubMed
    13. Longitudinal Analysis of Swallowing Displacement Kinematics After Oropharyngeal Cancer Treatment.
      Kidane J, Laus J, Gulati A, Gochman GE, Schneider SL, Chan JW, Yom SS, Ha P, Boscardin WJ, Ryan WR, Ma Y| | PubMed
    14. Feasibility of accelerated image-guided high-dose-rate interstitial brachytherapy with inverse planning simulated annealing (IPSA-HDRBT) for post-operative treatment of pathologically node-negative squamous cell carcinomas of the oral tongue.
      Cheung CK, Chew J, Wai K, Calkins SM, Ha PK, Ryan WR, Cunha A, Yom SS, Hsu IC, Chan JW| | PubMed
    15. Adverse radiation effect and freedom from progression following repeat stereotactic radiosurgery for brain metastases.
      Sneed PK, Chan JW, Ma L, Braunstein SE, Theodosopoulos PV, Fogh SE, Nakamura JL, Boreta L, Raleigh DR, Ziemer BP, Morin O, Hervey-Jumper SL, McDermott MW| | PubMed
    16. Meningioma DNA methylation groups identify biological drivers and therapeutic vulnerabilities.
      Choudhury A, Magill ST, Eaton CD, Prager BC, Chen WC, Cady MA, Seo K, Lucas CG, Casey-Clyde TJ, Vasudevan HN, Liu SJ, Villanueva-Meyer JE, Lam TC, Pu JK, Li LF, Leung GK, Swaney DL, Zhang MY, Chan JW, Qiu Z, Martin MV, Susko MS, Braunstein SE, Bush NAO, Schulte JD, Butowski N, Sneed PK, Berger MS, Krogan NJ, Perry A, Phillips JJ, Solomon DA, Costello JF, McDermott MW, Rich JN, Raleigh DR| | PubMed
    17. Safety of accelerated hypofractionated whole pelvis radiation therapy prior to high dose rate brachytherapy or stereotactic body radiation therapy prostate boost.
      Phuong C, Chan JW, Ni L, Wall P, Mohamad O, Wong AC, Hsu IC, Chang AJ| | PubMed
    18. Artificial Intelligence-Guided Prediction of Dental Doses Before Planning of Radiation Therapy for Oropharyngeal Cancer: Technical Development and Initial Feasibility of Implementation.
      Chan JW, Hohenstein N, Carpenter C, Pattison AJ, Morin O, Valdes G, Sanchez CT, Perkins J, Solberg TD, Yom SS| | PubMed
    19. Adverse radiation effects in volume-staged radiosurgery for large arteriovenous malformations: a multiinstitutional study.
      Seymour ZA, Chan JW, McDermott MW, Grills I, Ye H, Kano H, Lehocky CA, Jacobs RC, Lunsford LD, Chytka T, Lišcák R, Lee CC, Yang HC, Ding D, Sheehan JP, Feliciano CE, Rodriguez-Mercado R, Chiang VL, Hess JA, Sommaruga S, McShane B, Lee JYK, Vasas LT, Kaufmann AM, Sneed PK| | PubMed
    20. Should Sentinel Lymph Node Biopsy Status Guide Adjuvant Radiation Therapy in Patients With Merkel Cell Carcinoma?
      Ahmad TR, Vasudevan HN, Lazar AA, Chan JW, George JR, Alvarado MD, Yu SS, Daud A, Yom SS| | PubMed
    21. Timing of Urgent Inpatient Palliative Radiation Therapy.
      Wu SY, Yee E, Chan JW, Chapman CH, Boreta L, Braunstein SE| | PubMed
    22. Reduced-Dose Radiation Therapy for HPV-Associated Oropharyngeal Carcinoma (NRG Oncology HN002).
      Yom SS, Torres-Saavedra P, Caudell JJ, Waldron JN, Gillison ML, Xia P, Truong MT, Kong C, Jordan R, Subramaniam RM, Yao M, Chung CH, Geiger JL, Chan JW, O'Sullivan B, Blakaj DM, Mell LK, Thorstad WL, Jones CU, Banerjee RN, Lominska C, Le QT| | PubMed
    23. Gallium-68 prostate-specific membrane antigen ([68Ga]Ga-PSMA-11) PET for imaging of thyroid cancer: a feasibility study.
      Lawhn-Heath C, Yom SS, Liu C, Villanueva-Meyer JE, Aslam M, Smith R, Narwal M, Juarez R, Behr SC, Pampaloni MH, Chan JW, Glastonbury CM, Hope TA, Flavell RR| | PubMed
    24. Will the COVID Pandemic Lead to Uncounted Cancer Deaths in the Future?
      Chan JW, Lee VHF| | PubMed
    25. Estrogen/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival.
      Sperduto PW, Mesko S, Li J, Cagney D, Aizer A, Lin NU, Nesbit E, Kruser TJ, Chan J, Braunstein S, Lee J, Kirkpatrick JP, Breen W, Brown PD, Shi D, Shih HA, Soliman H, Sahgal A, Shanley R, Sperduto W, Lou E, Everett A, Boggs DH, Masucci L, Roberge D, Remick J, Plichta K, Buatti JM, Jain S, Gaspar LE, Wu CC, Wang TJC, Bryant J, Chuong M, Yu J, Chiang V, Nakano T, Aoyama H, Mehta MP| | PubMed
    26. Evaluation of a National Comprehensive Cancer Network Guidelines-Based Decision Support Tool in Patients With Non-Small Cell Lung Cancer: A Nonrandomized Clinical Trial.
      Wu SY, Lazar AA, Gubens MA, Blakely CM, Gottschalk AR, Jablons DM, Jahan TM, Wang VEH, Dunbar TL, Wong ML, Chan JW, Guthrie W, Belkora J, Yom SS| | PubMed
    27. DoseGAN: a generative adversarial network for synthetic dose prediction using attention-gated discrimination and generation.
      Kearney V, Chan JW, Wang T, Perry A, Descovich M, Morin O, Yom SS, Solberg TD| | PubMed
    28. Improved Tumor Control Related to Radiotherapy Technological Development for Hypopharyngeal Cancer.
      Susko MS, Lazar AA, Dhar S, Chan JW, Shiao SL, Chapman CH, Johnson J, Quivey JM, Ryan WR, Heaton CM, Ha PK, Yom SS| | PubMed
    29. Salvage Strategies for Neck Recurrences Are Individualized.
      Chan JW| | PubMed
    30. Attention-Aware Discrimination for MR-to-CT Image Translation Using Cycle-Consistent Generative Adversarial Networks.
      Kearney V, Ziemer BP, Perry A, Wang T, Chan JW, Ma L, Morin O, Yom SS, Solberg TD| | PubMed
    31. Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today.
      Sperduto PW, Mesko S, Li J, Cagney D, Aizer A, Lin NU, Nesbit E, Kruser TJ, Chan J, Braunstein S, Lee J, Kirkpatrick JP, Breen W, Brown PD, Shi D, Shih HA, Soliman H, Sahgal A, Shanley R, Sperduto W, Lou E, Everett A, Boggs DH, Masucci L, Roberge D, Remick J, Plichta K, Buatti JM, Jain S, Gaspar LE, Wu CC, Wang TJC, Bryant J, Chuong M, Yu J, Chiang V, Nakano T, Aoyama H, Mehta MP| | PubMed
    32. Diagnosis, Staging, Radiation Treatment Response Assessment, and Outcome Prognostication of Head and Neck Cancers Using PET Imaging: A Systematic Review.
      Hohenstein NA, Chan JW, Wu SY, Tahir P, Yom SS| | PubMed
    33. Dose response and architecture in volume staged radiosurgery for large arteriovenous malformations: A multi-institutional study.
      Seymour ZA, Chan JW, Sneed PK, Kano H, Lehocky CA, Jacobs RC, Ye H, Chytka T, Liscak R, Lee CC, Yang HC, Ding D, Sheehan J, Feliciano CE, Rodriguez-Mercado R, Chiang VL, Hess JA, Sommaruga S, McShane B, Lee J, Vasas LT, Kaufmann AM, Grills I, McDermott MW| | PubMed
    34. Attention-enabled 3D boosted convolutional neural networks for semantic CT segmentation using deep supervision.
      Kearney V, Chan JW, Wang T, Perry A, Yom SS, Solberg TD| | PubMed
    35. Dedicated Diagnostic Radiology/Radiation Oncology Rounds: Added Value Beyond Traditional Tumor Boards.
      Kallianos KG, Muhoozi BN, Gottschalk A, Yom SS, Chan JW, Henry TS, Elicker BM, Ordovas KG, Naeger DM| | PubMed
    36. A convolutional neural network algorithm for automatic segmentation of head and neck organs at risk using deep lifelong learning.
      Chan JW, Kearney V, Haaf S, Wu S, Bogdanov M, Reddick M, Dixit N, Sudhyadhom A, Chen J, Yom SS, Solberg TD| | PubMed
    37. Advances in multidisciplinary therapy for meningiomas.
      Brastianos PK, Galanis E, Butowski N, Chan JW, Dunn IF, Goldbrunner R, Herold-Mende C, Ippen FM, Mawrin C, McDermott MW, Sloan A, Snyder J, Tabatabai G, Tatagiba M, Tonn JC, Wen PY, Aldape K, Nassiri F, Zadeh G, Jenkinson MD, Raleigh DR, International Consortium on Meningiomas| | PubMed
    38. Ultraviolet light-related DNA damage mutation signature distinguishes cutaneous from mucosal or other origin for head and neck squamous cell carcinoma of unknown primary site.
      Chan JW, Yeh I, El-Sayed IH, Algazi AP, Glastonbury CM, Ha PK, Yom SS, van Zante A| | PubMed
    39. DoseNet: a volumetric dose prediction algorithm using 3D fully-convolutional neural networks.
      Kearney V, Chan JW, Haaf S, Descovich M, Solberg TD| | PubMed
    40. The application of artificial intelligence in the IMRT planning process for head and neck cancer.
      Kearney V, Chan JW, Valdes G, Solberg TD, Yom SS| | PubMed
    41. Reducing radiation-related morbidity in the treatment of nasopharyngeal carcinoma.
      Chan JW, Parvathaneni U, Yom SS| | PubMed
    42. Words of Wisdom. Re: Genomic Classifier Identifies Men with Adverse Pathology After Radical Prostatectomy Who Benefit from Adjuvant Radiation Therapy.
      Chan J, Roach M| | PubMed
    43. A Predictive Genetic Signature for Response to Fluoropyrimidine-Based Neoadjuvant Chemoradiation in Clinical Stage II and III Rectal Cancer.
      Chan J, Kinsella MT, Willis JE, Hu H, Reynolds H, Delaney C, McCulla A, Deharo S, Ahdesmäki M, Allen WL, Johnston PG, Kinsella TJ| | PubMed
    44. UVA phototransduction drives early melanin synthesis in human melanocytes.
      Wicks NL, Chan JW, Najera JA, Ciriello JM, Oancea E| | PubMed
    45. Fabrication of nanopores with embedded annular electrodes and transverse carbon nanotube electrodes.
      Jiang Z, Mihovilovic M, Chan J, Stein D| | PubMed